FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the use of a compound of formula (I) in the production of an injectable medicinal product for the treatment of cerebral infarction in humans.
EFFECT: use of the invention makes it possible to effectively treat cerebral infarction in humans.
1 cl, 5 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF CLINICAL COURSE OF ACUTE ISCHEMIC STROKE DURING 24 HOURS OF PERFORMING THROMBOLYTIC THERAPY | 2015 |
|
RU2573801C1 |
METHOD OF RECOVERING MOTOR FUNCTION IN PATIENTS IN ACUTE PERIOD OF ISCHEMIC STROKE IN POOL OF CAROTID SYSTEM ARTERIES | 2012 |
|
RU2508048C1 |
METHOD OF THROMBOLYTIC THERAPY IN STROKE | 2023 |
|
RU2820542C1 |
METHOD FOR MONITORING PATIENTS WITH ACUTE CEREBROVASCULAR ACCIDENT | 2023 |
|
RU2820541C1 |
METHOD FOR PREDICTING AN UNFAVORABLE OUTCOME IN PATIENTS WITH ISCHEMIC STROKE | 2021 |
|
RU2769488C1 |
METHOD FOR TREATMENT OF ISCHEMIC STROKE | 2018 |
|
RU2670203C1 |
PHARMACEUTICAL COMBINATION INCLUDING EPIDERMAL GROWTH FACTOR AND GHRP6 PEPTIDE AS A SECRETION STIMULATOR FOR RECOVERY AFTER BRAIN DAMAGE | 2019 |
|
RU2776812C1 |
METHOD FOR ESTIMATING THE REHABILITATION POTENTIAL OF A PATIENT WITH RECENTLY SUFFERED ISCHEMIC STROKE | 2021 |
|
RU2777805C1 |
METHOD FOR COMPLEX TREATMENT OF PATIENTS WITH ISCHEMIC STROKE IN THE ACUTE PERIOD AND AT THE STAGE OF EARLY REHABILITATION WITH APPLICATION OF INFRA-RED TERAHERTZ RADIATION | 2018 |
|
RU2706382C1 |
METHOD FOR IMPROVING EARLY FUNCTIONAL NEUROLOGIC RECOVERY IN PATIENTS WITH ISCHEMIC STROKE AND RESPIRATORY DEPRESSION IN SLEEP | 2017 |
|
RU2645410C1 |
Authors
Dates
2023-11-08—Published
2023-04-25—Filed